CSL

Sustainability Report and Carbon Intensity Rankings

Is CSL doing their part?

Their DitchCarbon score is 43

CSL has a DitchCarbon Score of 43 out of 100, indicating moderate performance in sustainability measures. This score reflects the company’s current carbon intensity, suggesting there is significant room for improvement in reducing emissions. A higher score would denote stronger efforts to lower carbon intensity and enhance overall sustainability.

This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.

Industry emissions intensity

Very low

Low

Medium

High

Very high

CSL operates in the health and social services industry, which has a low carbon intensity ranking. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.

Location emissions intensity

Very low

Low

Medium

High

Very high

CSL, located in Australia, operates in a region with a very high carbon intensity rating. This suggests that the company’s sustainability efforts may be challenged by the high carbon footprint associated with the local energy grid and industrial practices.

Unlock 30+ emissions intelligence data points

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

Unlock 30+ emissions data points on CSL

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

1.44%

...this company is doing 1.44% better in emissions than the industry average.

Founded in 1916, CSL is a global biotechnology company headquartered in Melbourne, Australia, specializing in the health and social services industry. The company is dedicated to developing and delivering a wide array of life-saving medicines, including treatments for haemophilia, primary immune deficiencies, and vaccines for influenza. With a strong commitment to innovation and a workforce of over 17,000 employees, CSL operates in more than 60 countries, providing therapies for use in cardiac surgery, organ transplantation, and burn treatment.

Compare CSL with other companies in the same industry –>

emission intelligence's platform recommendations for CSL

CSL should explore opportunities for fuel switching in their transportation and operations to potentially reduce their emissions by 15%.

Good news, CSL has made solid SBTi commitments

CSL has pledged to set science-based targets through the Science Based Targets initiative (SBTi) to reduce greenhouse gas emissions in line with climate science. This commitment means the company will develop a detailed plan to significantly cut its carbon footprint to prevent the worst impacts of climate change.

Participating

Claim this profile

Are you associate with this company?
Help us improve our data and claim this profile.

Our methodology

Read about our emission calculation methodologies, and what the DitchCarbon Score means.

Other company reports in this industry

Looking for a specific company?

Search our company directory or contact us for custom data requests.

CSL

Sustainability Report and Carbon Intensity Rankings

Is CSL doing their part?

Their DitchCarbon score is 43

Industry emissions intensity

Very low

Low

Medium

High

Very high

Location emissions intensity

Very low

Low

Medium

High

Very high

Unlock 30+ emissions intelligence data points

Unlock 30+ emissions data points on CSL

...this company is doing 1.44% better in emissions than the industry average.

emission intelligence's platform recommendations for CSL

Good news, CSL has made solid SBTi commitments

Claim this profile

Our methodology

Other company reports in this industry

Looking for a specific company?

Quicklinks

Resources

Get in touch